Also trades as: MDCX (NASDAQ) · $vol 1M
MDCXW NASDAQ
Medicus Pharma Ltd. Common Stock
1W: -3.2%
1M: -22.7%
3M: -34.5%
YTD: -88.0%
1Y: -65.9%
$0.30
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Balance Sheet Trends
Total Assets
$10M
+78.2% ▲
Total Liabilities
$10M
+299.0% ▲
Shareholders Equity
-$68K
-102.2% ▼
Cash & Investments
$9M
+109.0% ▲
Total Debt
$4M
+1139.8% ▲
Net Debt
-$5M
-22.6% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| — Assets — | |||
| Cash | $2M | $4M | $9M |
| Short-Term Investments | $0 | $0 | $0 |
| Cash & ST Investments | $2M | $4M | $9M |
| Net Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $1M |
| Total Current Assets | $2M | $5M | $10M |
| Property, Plant & Equip. | $0 | $268K | $171K |
| Goodwill & Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 |
| Total Non-Current Assets | $0 | $268K | $171K |
| Total Assets | $2M | $6M | $10M |
| — Liabilities — | |||
| Accounts Payable | $211K | $1M | $3M |
| Short-Term Debt | $0 | $116K | $4M |
| Deferred Revenue | $0 | $0 | $0 |
| Other Current Liabilities | $28K | $762K | $3M |
| Total Current Liabilities | $782K | $2M | $10M |
| Long-Term Debt | $0 | $0 | $19K |
| Other Non-Current Liab. | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $206K | $63K |
| Total Liabilities | $782K | $3M | $10M |
| — Equity — | |||
| Common Stock | $19M | $31M | $57M |
| Retained Earnings | -$18M | -$29M | -$64M |
| Accumulated OCI | $0 | $0 | $11K |
| Total Stockholders Equity | $1M | $3M | -$68K |
| Total Liabilities & Equity | $2M | $6M | $10M |
| — Key Metrics — | |||
| Total Debt | $0 | $322K | $4M |
| Net Debt | -$2M | -$4M | -$5M |
| Total Investments | $0 | $0 | $0 |